Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 2
1985 1
1987 2
1990 2
1991 2
1992 1
1995 1
1997 3
1999 1
2000 1
2002 3
2003 6
2004 1
2005 4
2006 5
2007 5
2008 3
2009 4
2010 6
2011 6
2012 3
2013 9
2014 8
2015 8
2016 9
2017 9
2018 9
2019 7
2020 4
2021 3
2022 4
2023 11
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

126 results

Results by year

Filters applied: . Clear all
Page 1
Apical Aneurysms and Mid-Left Ventricular Obstruction in Hypertrophic Cardiomyopathy.
Sherrid MV, Bernard S, Tripathi N, Patel Y, Modi V, Axel L, Talebi S, Ghoshhajra BB, Sanborn DY, Saric M, Adlestein E, Alvarez IC, Xia Y, Swistel DG, Massera D, Fifer MA, Kim B. Sherrid MV, et al. JACC Cardiovasc Imaging. 2023 May;16(5):591-605. doi: 10.1016/j.jcmg.2022.11.013. Epub 2023 Jan 11. JACC Cardiovasc Imaging. 2023. PMID: 36681586 Free article.
Improved Diagnostic Criteria for Apical Hypertrophic Cardiomyopathy.
Hughes RK, Shiwani H, Rosmini S, Augusto JB, Burke L, Jiang Y, Pierce I, Joy G, Castelletti S, Orini M, Kellman P, Xue H, Lopes LR, Mohiddin S, Treibel T, Manisty C, Captur G, Davies R, Moon JC. Hughes RK, et al. JACC Cardiovasc Imaging. 2024 May;17(5):501-512. doi: 10.1016/j.jcmg.2023.07.012. Epub 2023 Oct 11. JACC Cardiovasc Imaging. 2024. PMID: 37831014
BACKGROUND: There is no acceptable maximum wall thickness (MWT) threshold for diagnosing apical hypertrophic cardiomyopathy (ApHCM), with guidelines referring to 15 mm MWT for all hypertrophic cardiomyopathy subtypes. ...
BACKGROUND: There is no acceptable maximum wall thickness (MWT) threshold for diagnosing apical hypertrophic cardiomyopathy …
Apical hypertrophic cardiomyopathy--a benign condition?
Zimmerman DD, Bransted T, Geiger J. Zimmerman DD, et al. J Insur Med. 2014;44(2):118-21. J Insur Med. 2014. PMID: 25816471 Review.
Apical hypertrophic cardiomyopathy (ApHCM) is a less common type of hypertrophic cardiomyopathy (HCM) and is often characterized as benign. ...
Apical hypertrophic cardiomyopathy (ApHCM) is a less common type of hypertrophic cardiomyopathy (HCM) and is often char …
Right ventricular hypertrophy in apical hypertrophic cardiomyopathy.
Mihos CG, Escolar E, Fernandez R. Mihos CG, et al. Echocardiography. 2023 Jun;40(6):515-523. doi: 10.1111/echo.15588. Epub 2023 May 7. Echocardiography. 2023. PMID: 37149842
BACKGROUND: Right ventricular hypertrophy (RVH+) in hypertrophic cardiomyopathy occurs in one third of patients, however, outcomes in apical hypertrophic cardiomyopathy (ApHCM) have not been described. ...
BACKGROUND: Right ventricular hypertrophy (RVH+) in hypertrophic cardiomyopathy occurs in one third of patients, however, outcomes in api …
Invasive Cardiac Hemodynamics in Apical Hypertrophic Cardiomyopathy.
Malik AA, Saraswati U, Miranda WR, Covington M, Scott CG, Lee AT, Arruda-Olson A, Geske JB, Klarich KW, Anand V. Malik AA, et al. J Am Heart Assoc. 2024 May 7;13(9):e032520. doi: 10.1161/JAHA.123.032520. Epub 2024 Apr 30. J Am Heart Assoc. 2024. PMID: 38686858 Free article.
BACKGROUND: Symptomatic limitations in apical hypertrophic cardiomyopathy may occur because of diastolic dysfunction with resultant elevated left ventricular filling pressures, cardiac output limitation to exercise, pulmonary hypertension (PH), valvular abnor …
BACKGROUND: Symptomatic limitations in apical hypertrophic cardiomyopathy may occur because of diastolic dysfunction wi …
Loperamide Toxicity Revealing Apical Hypertrophic Cardiomyopathy.
Khan N, Chitturi KR, Hatcher C, Clewing M, Nagueh SF. Khan N, et al. Methodist Debakey Cardiovasc J. 2021 Apr 5;17(1):65-67. doi: 10.14797/VRZW9460. Epub 2021 Mar 25. Methodist Debakey Cardiovasc J. 2021. PMID: 34104323 Free PMC article.
This, in turn, can lead to frequent early afterdepolarizations, the most common mechanism of drug-induced long QT syndrome and torsades de pointes. Apical hypertrophic cardiomyopathy (AHCM) is a nonobstructive hypertrophic cardiomyopathy rarely associated wit …
This, in turn, can lead to frequent early afterdepolarizations, the most common mechanism of drug-induced long QT syndrome and torsades de p …
Apical aneurysm formation in apical hypertrophic cardiomyopathy: Pilot study with cardiac magnetic resonance.
Yang K, Yu SQ, Chen XY, Song YY, Yang SJ, Cui C, Zhao KK, Wei MD, Lu MJ, Zhao SH. Yang K, et al. Int J Cardiol. 2023 Jan 15;371:480-485. doi: 10.1016/j.ijcard.2022.09.024. Epub 2022 Sep 15. Int J Cardiol. 2023. PMID: 36115439
BACKGROUND: The dynamic changes and apical aneurysm formation in apical hypertrophic cardiomyopathy (HCM) have not been specifically described. ...
BACKGROUND: The dynamic changes and apical aneurysm formation in apical hypertrophic cardiomyopathy (HCM) have not been …
Ethnic and sex-related differences at presentation in apical hypertrophic cardiomyopathy: An observational cross-sectional study.
Khoury S, Bhatia RT, Marwaha S, Miles C, Kasiakogias A, Bunce N, Behr E, Papadakis M, Sharma S, Tome M. Khoury S, et al. Int J Cardiol. 2023 Nov 15;391:131265. doi: 10.1016/j.ijcard.2023.131265. Epub 2023 Aug 11. Int J Cardiol. 2023. PMID: 37574022 Free article.
BACKGROUND: We investigated whether ethnicity and sex are associated with different clinical presentations and cardiovascular magnetic resonance (CMR) findings in individuals with apical hypertrophic cardiomyopathy (ApHCM). METHODS: A retrospective observatio …
BACKGROUND: We investigated whether ethnicity and sex are associated with different clinical presentations and cardiovascular magnetic reson …
Ischaemic events in hypertrophic cardiomyopathy patients with and without atrial fibrillation: a systematic review and meta-analysis.
Ye TTS, Siah QZ, Tan BYQ, Ho JSY, Syn NLX, Teo YH, Teo YN, Yip JW, Yeo TC, Lin W, Wong RCC, Chai P, Chan B, Sharma VK, Yeo LLL, Sia CH. Ye TTS, et al. J Thromb Thrombolysis. 2023 Jan;55(1):83-91. doi: 10.1007/s11239-022-02713-6. Epub 2022 Oct 3. J Thromb Thrombolysis. 2023. PMID: 36192663 Review.
The incidence of stroke/ transient ischaemic attack was 9.30% (95% CI 6.64-12.87, p = 0.316) in the apical hypertrophic cardiomyopathy subgroup. Concomitant atrial fibrillation in hypertrophic cardiomyopathy increases the risk of thromboembolic events includi …
The incidence of stroke/ transient ischaemic attack was 9.30% (95% CI 6.64-12.87, p = 0.316) in the apical hypertrophic car …
126 results